Alcon Inc. Ordinary Shares

ALC

Alcon Inc. is a global leader in eye care, specializing in the development, manufacturing, and marketing of ophthalmic products including surgical devices, eye care, and contact lenses. Founded in Switzerland, the company has a strong presence worldwide and is known for its innovations in vision care and eye health solutions.

$80.00 -0.80 (-0.99%)
Dividend Yield 0.35%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
May 15, 2025$0.282025-05-142025-05-14
May 16, 2024$0.242024-05-142024-05-15
May 12, 2023$0.212023-05-102023-05-11
May 5, 2022$0.202022-05-032022-05-04
May 6, 2021$0.102021-05-042021-05-05

Dividends Summary

Company News

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider
GlobeNewswire Inc. • Sns Insider • December 7, 2025

The global ophthalmic drugs market is projected to grow from USD 37.35 billion in 2023 to USD 62.74 billion by 2032, driven by increasing eye disorders, advanced drug delivery methods, and rising healthcare awareness.

New Eye Tech Is Booming For Alcon, Stock Soars
Benzinga • Vandana Singh • November 12, 2025

Alcon reported Q3 sales of $2.59 billion, slightly missing consensus but beating earnings expectations. The company saw strong growth in surgical and vision care segments, with promising new technologies like Unity VCS and PanOptix Pro.

RxSight (RXST) Q2 Loss Beats Estimates
The Motley Fool • Jesterai • August 7, 2025

RxSight reported Q2 2025 financial results with mixed performance, experiencing a 4% revenue decline but improving gross margins and growing Light Adjustable Lens procedure volume by 13%.

UBS downgrades Envestnet stock amid Bain Capital acquisition agreement By Investing.com - Investing.com
Investing.com • Emilio Ghigini • July 16, 2024

Jefferies upgraded Cooper Companies' stock to 'Buy' from 'Hold', citing the company's strong positioning in the contact lens market, driven by factors like customer upgrades to daily silicone hydrogel lenses and Cooper's leadership in managing myopia.

Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H - Zacks Investment Research
Zacks Investment Research • Zacks Investment Research • July 15, 2024

The medical instruments industry is witnessing a shift towards digital healthcare, with increased adoption of AI and IoT. However, the industry is facing logistical challenges and higher unit costs due to supply chain disruptions and inflation. The article highlights five top picks in the industry with positive earnings estimate revisions.

Related Companies